Home / Brands / Orexigen Therapeutics
Orexigen Therapeutics Recalls
2 recalls on record · August 22, 2018 to November 14, 2018 · Drugs
November 14, 2018DrugsFDA
Orexigen Therapeutics, Inc. recalls Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distribute
Hazard: Container packaging defect.
August 22, 2018DrugsFDA
Orexigen Therapeutics, Inc. recalls Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed
Hazard: Defective Container: Customer complaints of punctures in the bottle.